JAZZ
Jazz Pharmaceuticals Plc
$125.1
Earnings Summary
Revenue | $1054.97Mn |
Net Profits | $215.06Mn |
Net Profit Margins | 20.38% |
Highlights
Jazz Pharmaceuticals Plc’s revenue jumped 8.52% since last year same period to $1054.97Mn in the Q3 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 3.04% jump in its revenue since last 3-months.
Jazz Pharmaceuticals Plc’s net profit jumped 46.48% since last year same period to $215.06Mn in the Q3 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 27.58% jump in its net profits since last 3-months.
Jazz Pharmaceuticals Plc’s net profit margin jumped 34.98% since last year same period to 20.38% in the Q3 2024. On a quarterly growth basis, Jazz Pharmaceuticals Plc has generated 23.81% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Jazz Pharmaceuticals Plc post its latest quarter earnings
EPS Estimate Current Quarter | 5.5 |
EPS Estimate Current Year | 5.5 |
Highlights
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current quarter stand at 5.5 - a 15.3% jump from last quarter’s estimates.
Jazz Pharmaceuticals Plc’s earning per share (EPS) estimates for the current year stand at 5.5.
Key Ratios
Key ratios of the Jazz Pharmaceuticals Plc post its Q3 2024 earnings
Earning Per Share (EPS) | 6.61 |
Highlights
Jazz Pharmaceuticals Plc’s earning per share (EPS) jumped 36.57% since last year same period to 6.61 in the Q3 2024. This indicates that the Jazz Pharmaceuticals Plc has generated 36.57% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | 4.77 | 5.3 | 11.11% |
2024-11-07 | 5.5 | 6.61 | 20.18% |
2024-05-02 | 4.18 | 2.68 | -35.89% |
₹0 US Stocks a/c Opening Fee